EW

Edwards Lifesciences Corp
NYSE
84.84
-0.48
-0.56%
Pre Market: 86.19 +1.35 +1.59% 04:38 12/18 EST
OPEN
85.76
PREV CLOSE
85.32
HIGH
86.19
LOW
84.67
VOLUME
36
TURNOVER
155.09M
52 WEEK HIGH
87.89
52 WEEK LOW
65.94
MARKET CAP
49.23B
P/E (TTM)
36.48
1D
5D
1M
3M
1Y
5Y
1D
RBC Capital Reaffirms Their Buy Rating on Edwards Lifesciences (EW)
TipRanks · 8h ago
Edwards Lifesciences Is Maintained at Hold by Canaccord Genuity
Dow Jones · 14h ago
Edwards Lifesciences Price Target Cut to $87.00/Share From $89.00 by Canaccord Genuity
Dow Jones · 14h ago
Edwards Lifesciences price target lowered to $87 from $89 at Canaccord
TipRanks · 21h ago
Edwards Lifesciences (EW): Reassessing Valuation After Strong Sales Growth and Upgraded Guidance
Simply Wall St · 1d ago
Positive Outlook for Edwards Lifesciences Amid CMS Coverage Expansion for TAVR Procedures
TipRanks · 1d ago
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks · 1d ago
Buy Rating for Edwards Lifesciences Amid Potential TAVR Coverage Expansion and Strategic Alignment
TipRanks · 1d ago
More
About EW
Edwards Lifesciences Corporation is the global structural heart company. The Company partners with clinicians and researchers and invests in research and development to improve care for those impacted by structural heart disease. Its product categories include Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), and Surgical Structural Heart. It provides transcatheter heart valve replacement technologies designed for the minimally-invasive replacement of aortic heart valves. TAVR category includes the Edwards SAPIEN 3, the Edwards SAPIEN 3 Ultra and the Edwards SAPIEN 3 Ultra RESILIA systems. TMTT category includes the PASCAL Precision transcatheter repair system, EVOQUE tricuspid valve replacement system and Cardioband tricuspid valve reconstruction system. Its INSPIRIS RESILIA aortic valve, offers RESILIA tissue and VFit technology. It is managed in various geographical regions, such as United States, Europe, Japan and Rest of World.

Webull offers Edwards Lifesciences Corp stock information, including NYSE: EW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading EW stock methods without spending real money on the virtual paper trading platform.